What began as a fun experiment last summer opened another door to track and field success for Violet Heidt. Heidt had just finished her sophomore season at Seton Catholic by placing fourth in the long ...
Dual jury verdicts this week have validated longstanding concerns about the dangers of social media for young people. But the U.S. lacks federal regulation that meaningfully addresses these harms.
One day at an Idaho hospital, half the newborns Dr. Tom Patterson saw didn’t get the vitamin K shots that have been given to babies for decades to prevent potentially deadly bleeding. On another recen ...
Farmers around the world are feeling the squeeze of the Iran war. Gas prices have shot up and fertilizer supplies are waning due to Tehran's near shutdown of the Strait of Hormuz ...
Nuclear power is getting a second look in Southeast Asia as countries prepare to meet surging energy demand as they vie for artificial intelligence-focused data centers.
The future of fish is looking a lot like … salami? And meatballs. And fried chicken. And breakfast sausage. And, of course, spareribs and burgers. This is America, after all.
Years before the rise of Instagram, Banksy figured out that the key to real influence lay in not being famous, exactly, but in being anonymous.
Reid and Lauren Plumlee thought they had escaped the hubbub of Portland when they moved to central Vancouver’s Southcliff neighborhood to start their family. Now, they’re worried Vancouver’s plans to ...
It’s costing more and more to gas up the hot rods that Donnie Beson has spent a lifetime tinkering with. He’s not questioning his support for President Donald Trump, but he feels as though the war in ...
The recent settlement of lawsuits against the National Association of Realtors changed real estate transactions around the country.
The price of a PlayStation is going up by another $100, the second time in less than a year that Sony has upped the price tag on its popular gaming console.
Four short years ago, Vancouver-based CytoDyn was embroiled in scandal. But a group of executives fought to bring the biotech company back from the brink and now hope its leronlimab drug can provide a ...